Cart
sales@molnova.com
Gavestinel sodium
CAS No. 153436-38-5
Gavestinel sodium( —— )
Catalog No. M33855 CAS No. 153436-38-5
Gavestinel (GV 150526) is a non-competitive NMDA receptor antagonist that is potent, selective and orally active.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 58 | Get Quote |
|
| 5MG | 85 | Get Quote |
|
| 10MG | 140 | Get Quote |
|
| 25MG | 228 | Get Quote |
|
| 50MG | 339 | Get Quote |
|
| 100MG | 489 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGavestinel sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionGavestinel (GV 150526) is a non-competitive NMDA receptor antagonist that is potent, selective and orally active.
-
DescriptionGavestinel (GV 150526A) is a potent, selective, orally active and non-competitive antagonist of NMDA receptor. Gavestinel binds to the glycine site of the NMDA receptor, with a pKi of 8.5. Gavestinel can be used for the research of acute ischemic stroke.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetiGluR
-
RecptoriGluR | NMDAR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number153436-38-5
-
Formula Weight397.19
-
Molecular FormulaC18H11Cl2N2NaO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (251.77 mM; Ultrasonic )
-
SMILESO=C(NC1=CC=CC=C1)/C=C/C2=C(C([O-])=O)NC3=CC(Cl)=CC(Cl)=C23.[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fabio RD, et, al. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site. J Med Chem. 1997 Mar 14;40(6):841-50.?
molnova catalog
related products
-
Traxoprodil
A potent and NR2B-selective NMDA receptor antagonist; potently protects cultured hippocampal neurons from glutamate toxicity (IC50=10 nM).
-
Eliprodil
Eliprodil (SL-820715) is a non-competitive NR2B-NMDA receptor antagonist, less potent for NR2A- and NR2C-containing receptors (IC50>100 uM).
-
Rislenemdaz hydrochl...
Rislenemdaz (MK 0657;CERC 301) is a potent, orally bioavailable, brain‐penetrant, NR2B-selective NMDA receptor (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM respectively.
